Published in Respir Res on September 24, 2014
DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database (Oxford) (2015) 1.71
Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014. Am J Respir Crit Care Med (2015) 1.12
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet (2015) 1.11
A needs assessment to determine the need for respiratory therapy in complex continuing care: A methods paper. Can J Respir Ther (2015) 1.07
From big data analysis to personalized medicine for all: challenges and opportunities. BMC Med Genomics (2015) 1.04
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res (2016) 0.84
Excess costs of comorbidities in chronic obstructive pulmonary disease: a systematic review. PLoS One (2015) 0.79
Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009. Prev Chronic Dis (2017) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res (2004) 25.99
Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 14.07
Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res (2010) 11.23
Pathway Commons, a web resource for biological pathway data. Nucleic Acids Res (2010) 9.18
Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 7.67
Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature (2011) 6.08
Systemic manifestations and comorbidities of COPD. Eur Respir J (2009) 5.90
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J (2008) 4.11
The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci U S A (2008) 3.41
Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev (2007) 3.03
Gitools: analysis and visualisation of genomic data using interactive heat-maps. PLoS One (2011) 2.74
Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke. Food Chem Toxicol (2002) 2.31
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax (2010) 2.26
The impact of cellular networks on disease comorbidity. Mol Syst Biol (2009) 2.23
HIPPIE: Integrating protein interaction networks with experiment based quality scores. PLoS One (2012) 2.17
Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol (2009) 2.03
The comparative toxicogenomics database: a cross-species resource for building chemical-gene interaction networks. Toxicol Sci (2006) 2.00
Current controversies and future perspectives in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.79
The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med (2012) 1.61
DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks. Bioinformatics (2010) 1.54
Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med (2010) 1.50
COPD and the solar system: introducing the chronic obstructive pulmonary disease comorbidome. Am J Respir Crit Care Med (2012) 1.44
Human diseases through the lens of network biology. Trends Genet (2012) 1.34
p21Cip1 restricts neuronal proliferation in the subgranular zone of the dentate gyrus of the hippocampus. Proc Natl Acad Sci U S A (2008) 1.31
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration (2010) 1.29
Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med (2011) 1.23
Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med (2010) 1.23
Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD. Thorax (2004) 1.15
Changing the burden of COPD mortality. Int J Chron Obstruct Pulmon Dis (2006) 1.11
β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies. Eur Respir J (2011) 0.95
Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans. Genetics (2004) 0.85
Concentration-dependent effects of adrenaline on the profile of insulin secretion from isolated human islets of Langerhans. J Endocrinol (1993) 0.84
ADRB2 haplotype is associated with glucose tolerance and insulin sensitivity in obese postmenopausal women. Obesity (Silver Spring) (2010) 0.80
Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities. Pharmacogenomics (2010) 0.80
Development of novel microarray methodology for the study of mutations in the SERPINA1 and ADRB2 genes--their association with Obstructive Pulmonary Disease and Disseminated Bronchiectasis in Greek patients. Clin Biochem (2009) 0.79
β2 -adrenergic receptor Thr164IIe polymorphism, blood pressure and ischaemic heart disease in 66 750 individuals. J Intern Med (2011) 0.78
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med (2015) 4.16
Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med (2012) 3.44
What is chronic obstructive pulmonary disease anyway?: Continua, categories, cut points, and moving beyond spirometry. Am J Respir Crit Care Med (2013) 3.39
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax (2010) 3.06
Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med (2009) 2.70
Obstructive sleep apnea in patients with typical atrial flutter: prevalence and impact on arrhythmia control outcome. Chest (2013) 2.69
The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med (2009) 2.60
Anti-tissue antibodies are related to lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 2.45
Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol (2009) 2.03
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.99
Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med (2002) 1.92
Telemedicine experience for chronic care in COPD. IEEE Trans Inf Technol Biomed (2006) 1.89
Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.79
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.72
Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc (2015) 1.72
Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol (2012) 1.68
The Semanticscience Integrated Ontology (SIO) for biomedical research and knowledge discovery. J Biomed Semantics (2014) 1.66
Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology (2006) 1.66
Inroads to predict in vivo toxicology-an introduction to the eTOX Project. Int J Mol Sci (2012) 1.64
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J (2011) 1.58
Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial. Eur Respir J (2013) 1.57
DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks. Bioinformatics (2010) 1.54
Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat (2006) 1.53
Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases. PLoS One (2011) 1.51
[Health information on the Internet and trust marks as quality indicators: vaccines case study]. Aten Primaria (2009) 1.49
[Daily living activity in chronic obstructive pulmonary disease: validation of the Spanish version and comparative analysis of 2 questionnaires]. Med Clin (Barc) (2007) 1.48
Training depletes muscle glutathione in patients with chronic obstructive pulmonary disease and low body mass index. Respiration (2006) 1.47
Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension. Liver Transpl (2007) 1.44
COPD and the solar system: introducing the chronic obstructive pulmonary disease comorbidome. Am J Respir Crit Care Med (2012) 1.44
Assessment of NER solutions against the first and second CALBC Silver Standard Corpus. J Biomed Semantics (2011) 1.43
OSIRIS: a tool for retrieving literature about sequence variants. Bioinformatics (2006) 1.42
Decreased plasma levels of orexin-A in sleep apnea. Respiration (2005) 1.42
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med (2013) 1.41
Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.41
[Relationship between expiratory muscle dysfunction and dynamic hyperinflation in advanced chronic obstructive pulmonary disease]. Arch Bronconeumol (2009) 1.40
[Global muscle dysfunction and exacerbation of COPD: a cohort study]. Med Clin (Barc) (2004) 1.40
Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med (2007) 1.40
[Usefulness of a lung cancer rapid diagnosis specialist clinic. Contribution of ultrasound bronchoscopy]. Arch Bronconeumol (2010) 1.39
CCL4L polymorphisms and CCL4/CCL4L serum levels are associated with psoriasis severity. J Invest Dermatol (2011) 1.39
[Usefulness of radial endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of mediastinal lymph nodes]. Arch Bronconeumol (2009) 1.38
Redox balance and cellular inflammation in the diaphragm, limb muscles, and lungs of mechanically ventilated rats. Anesthesiology (2010) 1.38
A multiscale simulation system for the prediction of drug-induced cardiotoxicity. J Chem Inf Model (2011) 1.38
Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol (1985) (2009) 1.38
Characteristics of asthma patients admitted to an intermediate respiratory care unit. Arch Bronconeumol (2013) 1.37
Physical activity and clinical and functional status in COPD. Chest (2009) 1.34
Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med (2007) 1.33
Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med (2010) 1.32
Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J (2011) 1.31
Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol (2013) 1.29
Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors. J Med Chem (2005) 1.26
Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2005) 1.25
Induced effects of sodium ions on dopaminergic G-protein coupled receptors. PLoS Comput Biol (2010) 1.25
The EU-ADR corpus: annotated drugs, diseases, targets, and their relationships. J Biomed Inform (2012) 1.23
Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.23
Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain. PLoS Comput Biol (2011) 1.21
Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J Clin Invest (2009) 1.16
Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLoS One (2012) 1.15
Varicose vein surgery: stripping versus the CHIVA method: a randomized controlled trial. Ann Surg (2010) 1.14
The role of external and matrix pH in mitochondrial reactive oxygen species generation. J Biol Chem (2008) 1.13
Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol (2011) 1.13
A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease. PLoS Comput Biol (2011) 1.13
OSIRISv1.2: a named entity recognition system for sequence variants of genes in biomedical literature. BMC Bioinformatics (2008) 1.13
Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014. Am J Respir Crit Care Med (2015) 1.12
[Diagnosis and management of chronic obstructive pulmonary disease: joint guidelines of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Latin American Thoracic Society (ALAT)]. Arch Bronconeumol (2008) 1.12
Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2012) 1.10
Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2003) 1.10
Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation. Am J Pathol (2004) 1.10
Bistability of mitochondrial respiration underlies paradoxical reactive oxygen species generation induced by anoxia. PLoS Comput Biol (2009) 1.10
Diagnosis and treatment of sleep apnea-hypopnea syndrome. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol (2011) 1.10
Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats. FEBS Lett (2005) 1.09
Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population. BMC Med Genet (2010) 1.08
From SNPs to pathways: integration of functional effect of sequence variations on models of cell signalling pathways. BMC Bioinformatics (2009) 1.08
[Clinical audit of patients admitted to hospital in Spain due to exacerbation of COPD (AUDIPOC study): method and organisation]. Arch Bronconeumol (2010) 1.06
Factors affecting the relationship between psychological status and quality of life in COPD patients. Health Qual Life Outcomes (2010) 1.06
Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J (2012) 1.05
Association of an SNP with intrathymic transcription of TSHR and Graves' disease: a role for defective thymic tolerance. Hum Mol Genet (2011) 1.05
Aging, sex differences, and oxidative stress in human respiratory and limb muscles. Free Radic Biol Med (2006) 1.05
Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology (2004) 1.04
ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression. Clin Infect Dis (2010) 1.03
High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest (2009) 1.02
α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest (2010) 1.02
Present and future challenges and limitations in protein-protein docking. Proteins (2010) 1.02
Telomere shortening in sleep apnea syndrome. Respir Med (2010) 1.01